Clinical Trial Update: Evaluation of Patients With Known or Suspected Heart Disease

View source ↗

Summary

A National Heart, Lung, and Blood Institute–sponsored clinical trial evaluating patients with known or suspected heart disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Diabetes Mellitus
• Dilated Cardiomyopathy
• Heart Failure
• Peripheral Artery Disease
• Pulmonary Hypertension
• Renal Artery Stenosis

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Peripheral Artery Disease, Coronary Disease | Status: COMPLETED